The PMI Study

A cohort observational study to assay natriuretic peptide levels in people who have had a Myocardial Infarction (MI) to determine if they are better prognostic indicators of death and all cardiovascular events after acute MI than other indices as well as a better reflection of the left ventricular function as assessed by Radionuclide Ventriculography

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12606000212550

Enrollment

1000

Registered

2006-05-30

Start date

1994-11-13

Completion date

2001-06-10

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an cohort observational study to assess whether natriuretic peptide levels are better prognostic indicators of death and all cardiovascular events after acute myocardial infarction than other indices, and also better reflect left ventricular function as assessed by radionuclide ventriculography and/or echocardiography. Measurements will be carried out, within 24-96 hours of onset of chest pain and again at 3-5 months and 12 months after acute infarction. Clinical History will be recorded for 5 years

Interventions

natriuretic peptide levels 24-96 hours post myocardial infarction and at 3-5 months and 12 months post discharge

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

Diagnosis of MI24-96h from symptoms onsetMale or female18-80 years of ageCK =400u/L.andchest pain or other symptoms suggesting myocardial ischaemiaorST elevation of = 1mm in 2 contigous ECG leadsor New pathological Q waves.

Exclusion criteria

Unable to provide informed consent.

Outcome results